Clinical Social Workers in Clarksville, AR Accepting Medicare
4 Clinical Social Workers found. Showing 1 - 4
 Rachel Pelissier, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1116 S Rogers St, Clarksville, AR 72830 Phone: 479-337-7327 Fax: 479-227-5002 |
Angella Watson-mchalffey Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 522 Mill Rd, Clarksville, AR 72830 Phone: 501-315-3344 |
 George Allen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 522 Mill Rd, Clarksville, AR 72830 Phone: 479-705-1301 |
Jane Estes, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 522 Mill Rd, Clarksville, AR 72830 Phone: 501-315-3344 |
News Archive
Teva Canada recalls Biomedic Acetaminophen with Codeine owing to missing child-resistant packaging
Teva Canada Limited, in consultation with Health Canada, is recalling one lot (#669745) of Biomedic Acetaminophen with Codeine (30 caplets with 300 mg acetaminophen and 8 mg codeine) due to missing child-resistant packaging.
Labopharm completes joint venture with Gruppo Angelini
Labopharm Inc. today announced that it has completed the previously announced transaction to establish a joint venture with Gruppo Angelini.
Unique omega-3 supplement improves lung function, reduces airway inflammation in asthmatics
An Indiana University study has found that a unique omega-3 supplement derived from the New Zealand green-lipped mussel significantly improved lung function and reduced airway inflammation in asthmatics who experience exercise-induced bronchoconstriction, also called exercise-induced asthma.
Fat and muscle mass may contribute to diabetes risk
Fat and muscle mass, as potentially determined by a person's ethnic background, may contribute to diabetes risk, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Bayer HealthCare Pharmaceuticals' ciprofloxacin DPI granted FDA orphan drug designation for CF treatment
Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients. A similar designation has already been granted by the European Medicines Agency.
› Verified 2 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Occupational Therapists